412
Views
1
CrossRef citations to date
0
Altmetric
Asthma Control

The lived experience of adherence to asthma medication in young adults (18–34 years)

, B.Pharm, MResORCID Icon, , PhDORCID Icon, , PhDORCID Icon & , PhD
Pages 2475-2490 | Received 05 Oct 2021, Accepted 11 Dec 2021, Published online: 29 Dec 2021

References

  • Edward K-L, Welch T. The extension of Colaizzi’s method of phenomenological enquiry. Contemp Nurse. 2011;39(2):163–171.
  • WHO. World Health Organization: WHO; 2020. [updated 20/5/2020. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma.
  • McDonald VM, Maltby S, Reddel HK, King GG, Wark PAB, Smith L, Upham JW, James AL, Marks GB, Gibson PG, et al. Severe asthma: current management, targeted therapies and future directions-A roundtable report. Respirology. 2017;22(1):53–60. doi:10.1111/resp.12957.
  • Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3(1):1–1. doi:10.1186/s40733-016-0029-3.
  • Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2.
  • CDC CfDCaP. Most Recent National Asthma Data US: Centers for Disease Control and Prevention (CDC). 2019. [updated 30/3/2021; cited 2021 26/11]. Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.
  • AANAC. Asthma Australia and National Asthma Council Canberra: Deloitte Access Economics: Hidden Cost of Asthma Report 2015. [cited 2020. Available from: https://www2.deloitte.com/au/en/pages/economics/articles/hidden-cost-asthma.html.
  • AIHW. Asthma Canberra: Australian Institute of Health and Welfare; 2019. [updated 30/8/2019; cited 2020 23/4]. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma/contents/asthma.
  • ABS. Australian Bureau of Statistics: National Health Survey; 2018. [updated 12/12. Available from: https://www.abs.gov.au/ausstats/[email protected]/Lookup/by%20Subject/4364.0.55.001∼2017-18∼Main%20Features∼Asthma∼35.
  • Petrie KJ, Perry K, Broadbent E, Weinman J. A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17(1):74–84. doi:10.1111/j.2044-8287.2011.02033.x.
  • Saini B. Health promotion: Good control is a puff away. Austral Pharm. 2014;33(8):49.
  • Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010;3(3):514–540. doi:10.3390/ph3030514.
  • WHO. World Health Organization 2003. [Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1.
  • George M. Adherence in asthma and COPD: new strategies for an old problem. Respir Care. 2018;63(6):818–831. doi:10.4187/respcare.05905.
  • Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.005.
  • Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–938. doi:10.1016/j.jaci.2010.07.019.
  • Zhang J, Chang VW, Giannis A, Wang J-Y. Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ. 2013;445-446:281–298. doi:10.1016/j.scitotenv.2012.12.061.
  • Custovic A, Johnston SL, Pavord I, Gaga M, Fabbri L, Bel EH, Le Souëf P, Lötvall J, Demoly P, Akdis CA, et al. EAACI position statement on asthma exacerbations and severe asthma. Allergy. 2013;68(12):1520–1531. doi:10.1111/all.12275.
  • AIHW AIoHaW. Asthma Cannbra 2020. [updated 25/8/2020; cited 2021 22/3]. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma.
  • ABS. Australian Bureau of Statistics: Australian Social Trends, Young adults; 2013. [Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/Lookup/4102.0Main+Features40April+2013.
  • 2011. pp 165.
  • Noble H, Smith J. Issues of validity and reliability in qualitative research. Evid Based Nurs. 2015;18(2):34–35. doi:10.1136/eb-2015-102054.
  • Sandelowski M. Rigor or rigor mortis: the problem of rigor in qualitative research revisited. ANS Adv Nurs Sci. 1993;16(2):1–8. doi:10.1097/00012272-199312000-00002.
  • Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Directions Prog Eval. 1986;1986(30):73–84. doi:10.1002/ev.1427.
  • Morse JM. Determining sample size. Sage Publications Sage CA: Thousand Oaks, CA; 2000.
  • Cain A, Reznik M. Asthma management in New York City schools: a classroom teacher perspective. J Asthma. 2016;53(7):744–750. doi:10.3109/02770903.2015.1135946.
  • Edward KL. The phenomenon of resilience in crisis care mental health clinicians. Int J Ment Health Nurs. 2005;14(2):142–148. doi:10.1111/j.1440-0979.2005.00371.x.
  • Colaizzi PF. Psychological research as the phenomenologist views it 1978. [Available from: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&as_ylo=1978&q=Psychological+research+as+the+phenomenologist+views+it&btnG=.
  • Arias SJ, Neffen H, Bossio JC, Calabrese CA, Videla AJ, Armando GA, Antó JM. Prevalence and features of asthma in young adults in urban areas of Argentina. Archiv Bronconeumol (English Edn). 2018;54(3):134–139. doi:10.1016/j.arbr.2018.01.014.
  • George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adher. 2019;13:1325–1334. doi:10.2147/PPA.S209532.
  • Janson SL, McGrath KW, Covington JK, Cheng S-C, Boushey HA. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol. 2009;123(4):840–846. doi:10.1016/j.jaci.2009.01.053.
  • Breivik G. Trends in adventure sports in a post-modern society. J Sport Soc. 2010;13(2):260–273. doi:10.1080/17430430903522970.
  • Ducharme FM, Zemek RL, Chalut D, McGillivray D, Noya FJD, Resendes S, Khomenko L, Rouleau R, Zhang X. Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med. 2011;183(2):195–203. doi:10.1164/rccm.201001-0115OC.
  • Khan R, Maharaj R, Seerattan N, Babwah F. Effectiveness of personalized written asthma action plans in the management of children with partly controlled asthma in Trinidad: a randomized controlled trial. J Trop Pediatr. 2014;60(1):17–26. doi:10.1093/tropej/fmt063.
  • Gaude GS, Hattiholi J, Chaudhury A. Role of health education and self-action plan in improving the drug compliance in bronchial asthma. J Family Med Prim Care. 2014;3(1):33–38. doi:10.4103/2249-4863.130269.
  • Eakin MN, Rand CS. Improving patient adherence with asthma self-management practices: what works? Ann Allergy Asthma Immunol. 2012;109(2):90–92. doi:10.1016/j.anai.2012.06.009.
  • Axelsson M, Lötvall J. Recent educational interventions for improvement of asthma medication adherence. Asia Pac Allergy. 2012;2(1):67–75. doi:10.5415/apallergy.2012.2.1.67.
  • Boulet L-P, Boulay M-È, Gauthier G, Battisti L, Chabot V, Beauchesne M-F, Villeneuve D, Côté P. Benefits of an asthma education program provided at primary care sites on asthma outcomes. J Respiratory Med. 2015;109(8):991–1000. doi:10.1016/j.rmed.2015.05.004.
  • Prabhakaran L, Lim G, Abisheganaden J, Chee C, Choo Y. Impact of an asthma education programme on patients’ knowledge, inhaler technique and compliance to treatment. Singapore Med J. 2006;47(3):225–231.
  • Boulet L-P, Vervloet D, Magar Y, Foster JM. Adherence: the goal to control asthma. Clin Chest Med. 2012;33(3):405–417. doi:10.1016/j.ccm.2012.06.002.
  • Koster ES, Philbert D, Winters NA, Bouvy ML. Adolescents’ inhaled corticosteroid adherence: the importance of treatment perceptions and medication knowledge. J Asthma. 2015;52(4):431–436. doi:10.3109/02770903.2014.979366.
  • Van Steenis MN, Driesenaar JA, Bensing JM, Van Hulten R, Souverein PC, Van Dijk L, et al. Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Prefer Adher. 2014;8:83.
  • Reddel H. Rational prescribing for asthma in adults–written asthma action plans. Aust Prescr. 2012;35(3):78–81. doi:10.18773/austprescr.2012.035.
  • Zainol AH, Ismail AF, Taib F, Norsa’adah B. Treatment adherence, knowledge, attitude and quality of life of adolescents with asthma in northeastern Malaysia. Bangladesh J Med Sci. 2020;19(1):73–82. doi:10.3329/bjms.v19i1.43875.
  • Zeiger RS, Schatz M, Dalal AA, Qian L, Chen W, Ngor EW, Suruki RY, Kawatkar AA. Utilization and costs of severe uncontrolled asthma in a managed-care setting. J Allergy Clin Immunol Pract. 2016;4(1):120–129. e3. doi:10.1016/j.jaip.2015.08.003.
  • Hickman M, Stokes P, Gammon S, Beard C, Inkster A. Moments like diamonds in space: savoring the ageing process through positive engagement with adventure sports. Ann Leisure Res. 2018;21(5):612–630. doi:10.1080/11745398.2016.1241151.
  • De Simoni A, Horne R, Fleming L, Bush A, Griffiths C. What do adolescents with asthma really think about adherence to inhalers? Insights from a qualitative analysis of a UK online forum. BMJ Open. 2017;7(6):e015245. doi:10.1136/bmjopen-2016-015245.
  • McCabe SE, Teter CJ, Boyd CJ, Wilens TE, Schepis TS. Sources of prescription medication misuse among young adults in the United States: the role of educational status. J Clin Psychiatry. 2018;79(2):33–40. doi:10.4088/JCP.17m11958.
  • Harrison JA, Mullen PD, Green L. A meta-analysis of studies of the health belief model with adults. Health Educ Res. 1992;7(1):107–116. doi:10.1093/her/7.1.107.
  • Maiman LA, Becker M. The health belief model: Origins and correlates in psychological theory. J Health Educ Monogr. 1974;2(4):336–353. doi:10.1177/109019817400200404.
  • Apter AJ, Reisine ST, Affleck G, Barrows ERIK, Zuwallack RL. Adherence with twice-daily dosing of inhaled steroids: socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6):1810–1817. doi:10.1164/ajrccm.157.6.9712007.
  • Olsen S, Smith S, Oei T, Douglas J. Health belief model predicts adherence to CPAP before experience with CPAP. Eur Respir J. 2008;32(3):710–717. doi:10.1183/09031936.00127507.
  • Yue Z, Li C, Weilin Q, Bin W. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. J Patient Educ Counsel. 2015;98(5):669–673. doi:10.1016/j.pec.2015.02.007.
  • McQuaid E. Barriers to medication adherence in asthma: the importance of culture and context. Ann Allergy Asthma Immunol. 2018;121(1):37–42. doi:10.1016/j.anai.2018.03.024.
  • Driesenaar J. Beliefs and Adherence regarding Inhaled Corticosteroids. Paying attention to patient-provider communication in community pharmacy practice Doctoral thesis [Sl: sn]; 2018.
  • Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JAM, Horne R. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64(1):47–54. doi:10.1016/j.jpsychores.2007.07.016.
  • Cole S, Seale C, Griffiths C. The blue one takes a battering’why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. BMJ Open. 2013;3(2):e002247. doi:10.1136/bmjopen-2012-002247.
  • Holley S, Walker D, Knibb R, Latter S, Liossi C, Mitchell F, Radley R, Roberts G. Barriers and facilitators to self-management of asthma in adolescents: an interview study to inform development of a novel intervention . Clin Exp Allergy. 2018;48(8):944–956. doi:10.1111/cea.13141.
  • Bosnic-Anticevich S, Kritikos V, Carter V, Yan KY, Armour C, Ryan D, Price D. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia. J Asthma. 2018;55(6):684–694. doi:10.1080/02770903.2017.1353611.
  • Ye Q, He X-O, D’Urzo A. A review on the safety and efficacy of inhaled corticosteroids in the management of asthma. Pulm Ther. 2017;3(1):1–18. doi:10.1007/s41030-017-0043-5.
  • Yakar H, Kanbay A. Evaluation of Corticophobia in Asthmatic Patients. Niger J Clin Pract. 2020;23(8):1033–1038. doi:10.4103/njcp.njcp_341_19.
  • MacDonell KK, Naar S, Gibson-Scipio W, Lam P, Secord E. The Detroit Young Adult Asthma Project: pilot of a technology-based medication adherence intervention for African-American emerging adults. J Adolescent Health. 2016;59(4):465–471. doi:10.1016/j.jadohealth.2016.05.016.
  • Rosen LD, Whaling K, Carrier LM, Cheever NA, Rokkum J. The media and technology usage and attitudes scale: an empirical investigation. J Comput Human Behav. 2013;29(6):2501–2511. doi:10.1016/j.chb.2013.06.006.
  • Laba T-L, Jan S, Zwar NA, Roughead E, Marks GB, Flynn AW, Goldman MD, Heaney A, Lembke KA, Reddel HK. Cost-related underuse of medicines for asthma-opportunities for improving adherence. J Allergy Clin Immunol Pract. 2019;7(7):2298–2306. e12. doi:10.1016/j.jaip.2019.03.024.
  • O’Byrne PM, Pedersen S, Carlsson L-G, Radner F, Thorén A, Peterson S, Ernst P, Suissa S. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med. 2011;183(5):589–595. doi:10.1164/rccm.201005-0694OC.
  • Bansal V, Mangi MA, Johnson MM, Festic E. Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis. AMA. 2015;44(2):135. doi:10.5644/ama2006-124.141.
  • To M, To Y, Yamada H, Ogawa C, Otomo M, Suzuki N, Sano Y. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma. Intern Med. 2004;43(8):674–678. doi:10.2169/internalmedicine.43.674.
  • McKeever T, Harrison TW, Hubbard R, Shaw D. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. J Chest. 2013;144(6):1788–1794. doi:10.1378/chest.13-0871.
  • Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol. 2017;83(9):2077–2086. doi:10.1111/bcp.13295.
  • Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY, Bae HW, Sim YS, Chang JH, Cho YJ, et al. Inhaled corticosteroids in asthma and the risk of pneumonia. Allergy Asthma Immunol Res. 2019;11(6):795–805. doi:10.4168/aair.2019.11.6.795.
  • The Lancet Respiratory Medicine. COVID-19 heralds a new era for chronic diseases in primary care. Lancet Respir Med. 2020;8(7):647. doi:10.1016/S2213-2600(20)30274-5.
  • Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–2385. doi:10.1016/j.jaip.2020.04.053.
  • Srinivasan A, Chakravorty I, Srinivasan K. Does concurrent existence of asthma or COPD affect susceptibility & outcomes to novel coronavirus infections?: a short review of evidence and mechanisms. Phys. 2020;6(1). doi:10.38192/1.6.1.2.
  • Cooper V, Metcalf L, Versnel J, Upton J, Walker S, Horne R. Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Resp Med. 2015;25(1):1–6. doi:10.1038/npjpcrm.2015.26.
  • Saini B, LeMay K, Emmerton L, Krass I, Smith L, Bosnic-Anticevich S, Stewart K, Burton D, Armour C. Asthma disease management—Australian pharmacists’ interventions improve patients’ asthma knowledge and this is sustained. Patient Educ Couns. 2011;83(3):295–302. doi:10.1016/j.pec.2011.05.001.
  • Lycett H, Wildman E, Raebel EM, Sherlock J-P, Kenny T, Chan AHY. Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence. Respir Med. 2018;141:180–189. doi:10.1016/j.rmed.2018.06.032.
  • knoema. Australia - Male to female ratio of the total population 2020. Available from: https://knoema.com/atlas/Australia/topics/Demographics/Population/Male-to-female-ratio.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.